Moore Capital Management’s Viridian Therapeutics VRDN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-140,000	Closed	-$4.09M	–	572
2022 Q4	$4.09M	Buy	+140,000	New	+$4.09M	0.1%	174